Stay updated with breaking news from Jeffreys Dover. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Since the epidermis overlying cNF is normal, "there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when you don't need to," Patricia Richey, MD, said.
GuruFocus Article or News written by Business Wire and the topic is about:
Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced positive topline efficacy and safety results from its Phase 2 multicenter, open-label study of investigational drug candidate DaxibotulinumtoxinA for Injection for the combined treatment of upper facial lines, which are comprised of glabellar (frown) lines (GL), dynamic...